Who Is Buying Intel? Hedge Fund Activity in 2026

Intel Corporation has been one of the most debated stocks on Wall Street. Once the undisputed king of semiconductors, INTC has undergone a massive transformation under its foundry strategy, betting billions on domestic chip manufacturing while competing against AMD, NVIDIA, and TSMC. For institutional investors, Intel represents a turnaround story with enormous upside potential — or a value trap depending on who you ask.

The latest 13F filings reveal a clear picture: the majority of tracked hedge funds are bullish on Intel. With 8 funds increasing positions against just 3 selling, institutional sentiment is tilting decisively toward accumulation. Here's the full breakdown.

Intel Institutional Snapshot

With a 2:1 buy-to-sell ratio among tracked institutional investors, Intel's 13F data suggests growing conviction in the company's strategic direction.

Who's Buying Intel in 2026?

Vanguard Group — $20.4B (404M shares, Increased)

Vanguard remains the single largest institutional holder of Intel with a staggering $20.4 billion position spanning roughly 404 million shares. The fact that Vanguard increased its already massive stake signals continued confidence from the world's largest asset manager. While Vanguard's moves are partly index-driven, the increase in holdings reflects Intel's growing weight in major indices.

State Street Global Advisors — $10.5B (Increased)

State Street, another institutional heavyweight, boosted its Intel position to approximately $10.5 billion. As the second-largest holder, State Street's increase aligns with Vanguard's bullish posture and reinforces the passive investment community's exposure to INTC.

Fidelity Investments — $1.4B (Increased)

Fidelity added to its Intel stake, bringing the total to $1.4 billion. As one of the most influential active managers, Fidelity's decision to increase its position carries significant weight. Their research teams see value in Intel's foundry pivot and its CHIPS Act-funded manufacturing expansion.

Citadel Advisors (Ken Griffin) — $659.7M (Increased)

Ken Griffin's Citadel increased its Intel position to $659.7 million, a meaningful bet from one of the world's most sophisticated multi-strategy hedge funds. Citadel's quantitative and fundamental teams appear to see upside in Intel's current valuation relative to its semiconductor peers.

Renaissance Technologies — $498.2M (Increased)

Jim Simons' legendary quant fund boosted its Intel holding to $498.2 million. Renaissance's algorithms have identified favorable patterns in INTC, and the increase suggests their models project continued price appreciation.

Millennium Management (Israel Englander) — $83.9M (Increased)

Millennium added to its Intel position, now holding $83.9 million. While smaller relative to the fund's total AUM, the increase signals conviction from Englander's pod-based investment teams. Millennium's structure means multiple independent portfolio managers chose to increase Intel exposure — it's a bottom-up consensus within the fund rather than a single top-down decision.

Who's Selling Intel?

Appaloosa Management (David Tepper) — $820.4M (Decreased)

David Tepper's Appaloosa trimmed its Intel position from a substantial holding, though it still maintains $820.4 million in INTC. Tepper may be taking profits after Intel's recent run or reallocating capital to higher-conviction ideas. Notably, Appaloosa remains one of the larger hedge fund holders even after reducing.

D.E. Shaw — $302.7M (Decreased)

D.E. Shaw, the quantitative powerhouse, reduced its Intel stake to $302.7 million. The fund's systematic models may have flagged near-term headwinds or identified better risk-adjusted opportunities elsewhere in the semiconductor space.

Two Sigma — $165.4M (Decreased)

Two Sigma also trimmed its Intel exposure to $165.4 million. As another quant-driven fund, Two Sigma's reduction could reflect algorithmic signals around Intel's short-term momentum or valuation metrics.

Notable Moves

Bridgewater Associates — NEW Position

The most eye-catching development in Intel's 13F data is Bridgewater Associates opening a brand-new position. Ray Dalio's firm is known for macro-driven, risk-parity strategies. Bridgewater initiating a stake in Intel suggests their macro models view the semiconductor sector — and Intel specifically — as well-positioned for the current economic environment. New positions from Bridgewater are relatively rare and always worth watching.

The Quant Split

An interesting dynamic emerges when you examine the quant funds: Renaissance Technologies is buying while D.E. Shaw and Two Sigma are selling. This divergence suggests different algorithmic models are reaching different conclusions about INTC's trajectory — a sign that the stock sits at an inflection point where reasonable models can disagree.

What This Signals

Intel's institutional flow data paints a cautiously bullish picture. The 8-to-3 buying advantage is significant, and the involvement of major names like Vanguard, Citadel, and Renaissance on the buy side adds credibility to the bull case.

Bridgewater's new position is the headline move. When a $150+ billion macro fund initiates exposure to a turnaround semiconductor stock, it suggests conviction that the broader macro environment supports Intel's recovery thesis. The CHIPS Act funding, reshoring trends, and AI-driven semiconductor demand all play into this narrative.

The selling side is notable but not alarming. Appaloosa, D.E. Shaw, and Two Sigma reduced positions but didn't exit entirely, suggesting profit-taking rather than a fundamental bearish shift. With $820.4 million still on the table, Tepper clearly hasn't given up on Intel. The combined selling of approximately $1.3 billion is significant, but it's overwhelmed by the buying volume from Vanguard, State Street, Fidelity, and the hedge fund community.

Intel's $56 billion in tracked institutional value places it firmly in the semiconductor major leagues alongside AMD and Broadcom. The CHIPS Act funding — with Intel receiving the largest allocation of any U.S. chipmaker — provides a government-backed catalyst that few other semiconductor companies enjoy. Fabs in Arizona, Ohio, and Germany represent a generational investment in domestic manufacturing capacity.

The 5 funds holding steady add stability to the ownership base. When combined with the strong buy-side activity, Intel's institutional backing appears solid heading into the next quarter.

For retail investors watching the smart money, the message is clear: most institutional players are accumulating Intel, not abandoning it. Whether the foundry strategy ultimately succeeds remains the key question, but the 13F data suggests the big money is betting on Pat Gelsinger's vision.

Track Intel Institutional Activity

Track INTC institutional moves in real-time with Freenance Smart Money — we track 35 funds with $21.4T total AUM across 77,111 positions. See who's buying and selling at app.freenance.io/smart-money/ticker/INTC.

Related Articles

• Who Is Buying NVIDIA? Hedge Fund Activity in 2026
• Who Is Buying Apple? Hedge Fund Activity in 2026
• Who Is Buying Tesla? Hedge Fund Activity in 2026

FAQ

Why are hedge funds buying Intel (INTC) right now?

The 13F data shows an 8-to-3 buy-to-sell ratio, with funds like Vanguard, Citadel, and Renaissance increasing positions. Many institutions appear attracted to Intel's foundry pivot, the multi-billion CHIPS Act allocation, and a valuation that lags semiconductor peers. The thesis is essentially a turnaround bet on domestic chip manufacturing.

How does the CHIPS Act affect Intel's institutional appeal?

Intel received the largest single CHIPS Act allocation among U.S. chipmakers, providing government-backed funding for fabs in Arizona, Ohio, and Germany. For institutions, this de-risks the capital expenditure cycle and gives Intel a policy tailwind that pure-play foundries like TSMC do not enjoy on U.S. soil. The data treats this as part of the broader reshoring narrative.

What does Bridgewater's new position in INTC signal?

Bridgewater is primarily a macro and risk-parity shop, so new single-name positions are uncommon. A fresh stake in Intel suggests their macro models view the semiconductor cycle and U.S. industrial policy as supportive. It is one data point among many — not a recommendation — but it tends to be watched closely by other allocators.

Why are quant funds split on Intel?

Renaissance Technologies is adding while D.E. Shaw and Two Sigma are trimming, which signals that different quantitative models are weighting Intel's factors differently. This kind of divergence usually appears at inflection points where momentum, value, and quality signals disagree. It is informational only and does not point to a single "correct" view.

What are the main risks reflected in the Intel 13F data?

The selling from Appaloosa, D.E. Shaw, and Two Sigma — roughly $1.3B combined — reflects concerns around execution risk on the foundry strategy, margin pressure during the manufacturing build-out, and competition from TSMC, AMD, and NVIDIA. None of the sellers exited entirely, suggesting profit-taking rather than a structural bearish call. This page is informational and not investment advice.